Kynam Capital Management, LP Tyra Biosciences, Inc. Transaction History
Kynam Capital Management, LP
- $1.28 Billion
- Q2 2024
A detailed history of Kynam Capital Management, LP transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Kynam Capital Management, LP holds 566,715 shares of TYRA stock, worth $9.29 Million. This represents 0.71% of its overall portfolio holdings.
Number of Shares
566,715
Previous 515,190
10.0%
Holding current value
$9.29 Million
Previous $8.45 Million
7.24%
% of portfolio
0.71%
Previous 0.89%
Shares
3 transactions
Others Institutions Holding TYRA
# of Institutions
80Shares Held
43.3MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA10.4MShares$171 Million2.51% of portfolio
-
Boxer Capital, LLC San Diego, CA6.45MShares$106 Million5.73% of portfolio
-
Bvf Inc San Francisco, CA4.66MShares$76.4 Million2.28% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA4.41MShares$72.3 Million97.89% of portfolio
-
Nextech Invest Ag4.06MShares$66.5 Million12.24% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $688M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...